Venous thromboembolism associated with enhanced survival for patients undergoing concurrent chemoradiation (55 Gy/20f/4w plus cisplatinum and vinorelbine) for inoperable NSCLC

被引：0
|
作者：
Jones, S. [1 ]
Kelly, V. [2 ]
Maguire, J. [2 ]
机构：
[1] Clatterbridge Canc Ctr, Radiotherapy, Liverpool, Merseyside, England
[2] Liverpool Heart & Chest Hosp, Res Dept, Liverpool, Merseyside, England
来源：
LUNG CANCER | 2015年 / 87卷
关键词：
D O I：
10.1016/S0169-5002(15)50142-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
148
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 3 条
  • [1] Prospective quality of life measurement in SOCCAR - no disadvantage for patients receiving concurrent vs sequential treatment with 55 Gy/20f and cisplatinum/vinorelbine
    Maguire, J.
    McMenemin, R.
    O'Rourke, N.
    Peedell, C.
    Snee, M.
    McNee, S.
    Kelly, V.
    Khan, I.
    Slade, R.
    LUNG CANCER, 2012, 75 : S45 - S45
  • [2] Pre-SOCCAR pilot study of concurrent chemoradiation using 55 Gy in 20 fractions with cisplatinum and vinorelbine in stage III NSCLC
    Maguire, J.
    Mohammed, N.
    Hicks, J.
    Appel, W.
    Skailes, G.
    McMenemin, R.
    Mulvenna, P.
    Peedell, C.
    Kelly, V.
    LUNG CANCER, 2012, 75 : S45 - S45
  • [3] Concurrent chemoradiation using cisplatinum, vinorelbine, and radical radiotherapy with 20 fractions in 4 weeks for patients with inoperable NSCLC and good performance status
    Maguire, J
    Smith, N
    Kelly, V
    Smyth, C
    Ledson, M
    Walshaw, M
    THORAX, 2004, 59 : 52 - 52
1